Effect of Antibiotic Treatment on the Intestinal Metabolome

ABSTRACT The importance of the mammalian intestinal microbiota to human health has been intensely studied over the past few years. It is now clear that the interactions between human hosts and their associated microbial communities need to be characterized in molecular detail if we are to truly understand human physiology. Additionally, the study of such host-microbe interactions is likely to provide us with new strategies to manipulate these complex systems to maintain or restore homeostasis in order to prevent or cure pathological states. Here, we describe the use of high-throughput metabolomics to shed light on the interactions between the intestinal microbiota and the host. We show that antibiotic treatment disrupts intestinal homeostasis and has a profound impact on the intestinal metabolome, affecting the levels of over 87% of all metabolites detected. Many metabolic pathways that are critical for host physiology were affected, including bile acid, eicosanoid, and steroid hormone synthesis. Dissecting the molecular mechanisms involved in the impact of beneficial microbes on some of these pathways will be instrumental in understanding the interplay between the host and its complex resident microbiota and may aid in the design of new therapeutic strategies that target these interactions.

[1]  B. Finlay,et al.  The role of the intestinal microbiota in enteric infection , 2009, The Journal of physiology.

[2]  S. Mazmanian,et al.  The gut microbiota shapes intestinal immune responses during health and disease , 2009, Nature Reviews Immunology.

[3]  J. Jansson,et al.  Metabolomics Reveals Metabolic Biomarkers of Crohn's Disease , 2009, PloS one.

[4]  S. Levy,et al.  Antibacterial resistance worldwide: causes, challenges and responses , 2004, Nature Medicine.

[5]  A. Macpherson,et al.  Immune adaptations that maintain homeostasis with the intestinal microbiota , 2010, Nature Reviews Immunology.

[6]  S. Gorbach,et al.  Modification of bile acids by intestinal bacteria. , 1972, Archives of internal medicine.

[7]  R. Ley,et al.  Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine , 2006, Cell.

[8]  I. Rusyn,et al.  Towards high-throughput metabolomics using ultrahigh-field Fourier transform ion cyclotron resonance mass spectrometry , 2008, Metabolomics.

[9]  E. Zoetendal,et al.  analysis of the gastrointestinal tract microbiota High-throughput diversity and functionality , 2008 .

[10]  W. Whitman,et al.  Prokaryotes: the unseen majority. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Calder.  Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. , 2009, Biochimie.

[12]  K. Shimada,et al.  Deconjugation of bile acids by intestinal bacteria: review of literature and additional studies. , 1969, Journal of Infectious Diseases.

[13]  N. Fairweather,et al.  Antibiotic Treatment of Clostridium difficile Carrier Mice Triggers a Supershedder State, Spore-Mediated Transmission, and Severe Disease in Immunocompromised Hosts , 2009, Infection and Immunity.

[14]  E. Sternberg,et al.  The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease , 2008, Journal of leukocyte biology.

[15]  M. Rantalainen,et al.  Top-down systems biology modeling of host metabotype-microbiome associations in obese rodents. , 2009, Journal of proteome research.

[16]  L. Morelli.  Postnatal development of intestinal microflora as influenced by infant nutrition. , 2008, The Journal of nutrition.

[17]  G. Vinson.  The adrenal cortex and life , 2009, Molecular and Cellular Endocrinology.

[18]  M. Icaza-Chávez.  Gut microbiota in health and disease , 2013 .

[19]  Weiwen Zhang,et al.  Integrating multiple 'omics' analysis for microbial biology: application and methodologies. , 2010, Microbiology.

[20]  J. Farrar,et al.  Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi , 2009, Proceedings of the National Academy of Sciences.

[21]  B. Finlay,et al.  Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. , 2007, Cell host & microbe.

[22]  C. Funk,et al.  Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.

[23]  D. Raoult,et al.  Review of microarray studies for host-intracellular pathogen interactions. , 2010, Journal of microbiological methods.

[24]  Kellen L. Olszewski,et al.  Host-parasite interactions revealed by Plasmodium falciparum metabolomics. , 2009, Cell host & microbe.

[25]  E. Zoetendal,et al.  High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota , 2008, Gut.

[26]  A. Neish,et al.  REVIEWS IN BASIC AND CLINICAL GASTROENTEROLOGY Microbes in Gastrointestinal Health and Disease , 2009 .

[27]  M. Hogardt,et al.  Pretreatment of Mice with Streptomycin Provides a Salmonella enterica Serovar Typhimurium Colitis Model That Allows Analysis of Both Pathogen and Host , 2003, Infection and Immunity.

[28]  B. Finlay,et al.  Salmonella typhimurium Infection and Lipopolysaccharide Stimulation Induce Similar Changes in Macrophage Gene Expression1 , 2000, The Journal of Immunology.

[29]  P. Ayoubi,et al.  Coxiella burnetii Nine Mile II proteins modulate gene expression of monocytic host cells during infection , 2010, BMC Microbiology.

[30]  Christoph H Borchers,et al.  Metabolomics: towards understanding host-microbe interactions. , 2010, Future microbiology.

[31]  B. Finlay,et al.  Antibiotic-Induced Perturbations of the Intestinal Microbiota Alter Host Susceptibility to Enteric Infection , 2008, Infection and Immunity.

[32]  N. Pace,et al.  Gastrointestinal microbiology enters the metagenomics era , 2008, Current opinion in gastroenterology.

[33]  Karsten Suhre,et al.  MassTRIX: mass translator into pathways , 2008, Nucleic Acids Res..

[34]  D. Savage.  Microbial ecology of the gastrointestinal tract. , 1977, Annual review of microbiology.